| Financial Year |
March 31 2023 |
| Monetary Funds |
655,884,413.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,467,306.42 |
| Accounts Receivable |
1,717,425,213.24 |
| Advances to Suppliers |
257,480,687.52 |
| Other Receivables |
46,375,848.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
930,751,895.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,816,300.65 |
| Other Current Assets |
19,487,451.68 |
| Total Current Assets |
3,860,004,394.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,690,384.93 |
| Investment Properties |
21,006,861.03 |
| Fixed Assetes |
1,011,911,408.30 |
| Under-construction Projects |
28,740,684.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
354,927,387.96 |
| R&D expenses |
875.64 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,000,894.53 |
| Deferred Income Tax Assets |
44,354,397.92 |
| Other Non-Current Assets |
219,696,801.52 |
| Sub-Total of Non-Current Assets |
1,724,726,045.52 |
| Total Assets |
5,584,730,440.00 |
| Short-Term Loans |
1,529,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
132,479,539.64 |
| Accounts Payable |
1,586,549,909.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,723,132.61 |
| Taxes Payable |
20,656,706.25 |
| Interest Payable |
-- |
| Dividend Payable |
279,483.06 |
| Other payables |
91,428,033.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
886,226,889.39 |
| Other Current Liabilities |
70,503,757.49 |
| Sub-Total of Current Liabilities |
4,572,234,188.62 |
| Long-term Loans |
106,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,344,050.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
147,515,065.38 |
| Total Liabilities |
4,719,749,254.00 |
| Paid-In Capital(Or Share Stock) |
1,841,528,480.00 |
| Capital Surplus |
3,985,487,462.90 |
| Surplus Reserve |
325,620,954.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,446,614,439.48 |
| Minority Stockholder's Interest |
127,865,966.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
737,115,219.29 |
| Owner's Equity（Stockholder's Equity） |
864,981,186.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,584,730,440.00 |
